Octave Bioscience
Alexander Hari is a knowledgeable research associate at Octave Bioscience, contributing to precision medicine for neurodegenerative diseases since August 2023. Previously, Alexander served as an associate recruiter and recruiting sourcing associate at JGB BioPharma Consulting Inc., where efforts focused on matching qualified candidates with specialized roles. Experience also includes a role as VP of Product at Fraqtal, an impact-first investment platform in the psychedelic industry, and a product intern position at Tabula Rasa Ventures, where foundational website designs were created. Additional contributions were made as a college mentor in the Elevate Math program at the Silicon Valley Education Foundation, and as a civil engineering intern at Monterey Bay Engineers Inc. Alexander holds a Bachelor of Science in Neuroscience from UCLA.
Octave Bioscience
Octave Bioscience’s Comprehensive Care Platform provides a quantitative, objective measurement system designed to expand clinical insights in neurodegenerative disease, beginning with MS. It provides multiple layers of insight to provide a 360 degree view with a longitudinal perspective of disease progression. The first layer measures the patient’s underlying biology with blood based biomarkers that quantitatively and objectively assess inflammation and immune modulation. The second layer includes advanced measurement using improved MRI readings and interpretation to reveal more insights at the CNS layer, including the brain and spine. The final layer features real time tracking of symptoms via monitoring with mobile tools, sensors and wearables to identify changes in disease and alert care teams. All of this data is integrated into protocols, supported by decision support tools and feeds into a dashboard for ease of use. The Octave Platform allows individual and population views to facilitate better stratification and contextual interventions.